Post-exposure prophylaxis-in-pocket (PIP) was associated with healthcare savings and improved quality of life outcomes compared to pre-exposure prophylaxis (PrEP), based on data presented at ...

Only 4 percent of sexually active gay and bisexual men in the United States are using PrEP, according to a recently published study, showing that more must be done to reach everyone who could benefit ...

Peter Staley at CROI 2026 on defending 45 years of HIV progress: how clinicians, payers, and advocates can resist—quietly or publicly—and why it matters.

A U.S. study by San Diego State University and the RAND Corporation found that intimate partner violence among sexual minority men does not directly reduce PrEP use but can increase stigma and lower ...

A new study found that adults in custody of the Federal Bureau of Prisons have seen improved pre-exposure prophylaxis (PrEP) initiation and sustained treatment uptake for HIV. Rates of HIV ...

HIV (human immunodeficiency virus) remains a significant global health challenge, affecting millions of people worldwide. While advancements in medical science have led to better management of the ...

Please provide your email address to receive an email when new articles are posted on . PrEP coverage in the U.S. between 2012-2021 ranged from 3.8% in West Virginia to 22.2% in New York. Australian ...

Cullen Smith takes an HIV preventative medication every day for “added security” and “peace of mind” after he thought he may have contracted the disease from a partner last year. “Once that situation ...

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

Please provide your email address to receive an email when new articles are posted on . The proportion of transgender patients prescribed gender-affirming hormone therapy also rose. Clinicians can use ...

India introduced PrEP guidelines in 2022, but access remains limited due to lack of public rollout, low awareness, and high costs. Meanwhile, HIV prevalence has declined overall but remains ...